Characteristics of study sample | Â | Utilization rate of ED services | Hospitalization | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Total | Non-use | Use | Testing the consistency of distribution of subjects | Non-use | Use | Testing the consistency of distribution of subjects | |||||||
 | Subjects | Rate (%) | Subjects | Rate (%) | Subjects | Rate (%) | X 2 p value (Sig. level) |  | Subjects | Rate (%) | Subjects | Rate (%) | X 2 p value (Sig. level) |  |
Utilization rate of ED services | Hospitalization | |||||||||||||
Total | 280,840 | 100 | 266,817 | 100 | 14,023 | 100 | Â | Â | 220,856 | 100 | 59,984 | 100 | Â | Â |
Age | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 ≤ 18 | 21,591 | 7.69 | 21,168 | 7.93 | 423 | 3.02 | 0.0000 * |  | 19,611 | 8.88 | 1,980 | 3.3 | 0.00000 * |  |
 18 ~ 64 | 148,015 | 52.7 | 142,738 | 53.5 | 5,277 | 37.63 |  |  | 122,522 | 55.48 | 25,493 | 42.5 |  |  |
 ≥ 65 | 111,234 | 39.61 | 102,911 | 38.57 | 8,323 | 59.35 |  |  | 78,723 | 35.64 | 32,511 | 54.2 |  |  |
Sex | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Male | 127,387 | 45.36 | 120,173 | 45.04 | 7,214 | 51.44 | 0.0000 * |  | 97,268 | 44.04 | 30,119 | 50.21 | 0.00000 * |  |
 Female | 153,453 | 54.64 | 146,644 | 54.96 | 6,809 | 48.56 |  |  | 123,588 | 55.96 | 29,865 | 49.79 |  |  |
Income status | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
 Non low-income | 276,017 | 98.28 | 262,491 | 98.38 | 13,526 | 96.46 | 0.0000 * |  | 217,750 | 98.59 | 58,267 | 97.14 | 0.00000 * |  |
 Low-income | 4,823 | 1.72 | 4,326 | 1.62 | 497 | 3.54 |  |  | 3,106 | 1.41 | 1,717 | 2.86 |  |  |
Disability status | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | ||
 No | 233,285 | 83.07 | 224,270 | 84.05 | 9,015 | 64.29 | 0.0000 * |  | 191,523 | 86.72 | 41,762 | 69.62 | 0.00000 * |  |
 Yes | 47,555 | 16.93 | 42,547 | 15.95 | 5,008 | 35.71 |  |  | 29,333 | 13.28 | 18,222 | 30.38 |  |  |
Catastrophic illnesses | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | ||
 No | 235,420 | 83.83 | 225,759 | 84.61 | 9,661 | 68.89 | 0.0000 * |  | 194,269 | 87.96 | 41,151 | 68.6 | 0.00000 * |  |
 Yes | 45,420 | 16.17 | 41,058 | 15.39 | 4,362 | 31.11 |  |  | 26,587 | 12.04 | 18,833 | 31.4 |  |  |
Charlson Comorbidity Index score | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||
 0 | 90,919 | 32.37 | 89,451 | 33.53 | 1,468 | 10.47 | 0.0000 * |  | 82,918 | 37.54 | 8,001 | 13.34 | 0.00000 * |  |
 1 ~ 2 | 119,165 | 42.43 | 114,846 | 43.04 | 4,319 | 30.8 |  |  | 98,437 | 44.57 | 20,728 | 34.56 |  |  |
 ≥ 3 | 70,756 | 25.19 | 62,520 | 23.43 | 8,236 | 58.73 |  |  | 39,501 | 17.89 | 31,255 | 52.11 |  |  |
 2 | 208,663 | 74.3 | 199,887 | 74.92 | 8,776 | 62.58 | 0.0000 * |  | 169,842 | 76.9 | 38,821 | 64.72 | 0.00000 * |  |
 ≥ 3 | 72,177 | 25.7 | 66,930 | 25.09 | 5,247 | 37.42 |  |  | 51,014 | 23.1 | 21,163 | 35.28 |  |  |